Stock screenerAll disclosures →
EDGAR →
PCRX
Conviction 54HealthcareScan · Thu, Jun 25, 2026PCRX$24.34+1.57%
ResistanceSupportVol 14Insider sellVol MA14 546.3K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price24.34
Change+1.57%
Gap-0.08%
Rel volume3.84×
Avg volume499.7K
Avg $ vol11.57M
SMA 2023.04
SMA 5023.62
SMA 20023.44
Price vs 50+3.04%
Price vs 200+3.82%
MA stackbullish
50/200 cross—
Supertrenddown · 24.97
RSI (14)62
MACD hist0.17
MACD crossbull · 2d
Stoch %K / %D95 / 86
ADX (14)12
+DI / −DI29 / 16
RSI divergence—
MACD divergence—
ATR %+3.49%
ADR %3.31%
52w high27.22
52w low19.16
From 52w high-10.60%
Above 52w low+27.01%
New 52w highNo
SqueezeOn · 19d
Bollinger width9.33%
%B1.10
Donchian pos94.92%
Donchian high24.46
Donchian low22.00
AVWAP (52w high)23.39
vs AVWAP high+4.04%
AVWAP (52w low)22.67
vs AVWAP low+7.35%
OBV trendUp
Chaikin MF (20)-0.14
Today vs 20d3.84×
Avg vol (14d)546.3K
Avg vol (20d)499.7K
Avg $ vol (20d)11.57M
Market cap957.53M
RS 3m (vs SPY)-8.98%
RS 6m (vs SPY)-16.81%
RS line new highNo
Trend template3/8
Technical rank54.9
1 week+7.49%
1 month-0.10%
3 months+3.60%
6 months-6.48%
1 year-1.16%
YTD-0.51%
P/E136.13
P/B1.46
P/S1.32
P/FCF7.01
EPS0.1600
Div yield—
ROE1.08%
ROA0.58%
Debt/Eq0.56
Current4.73
EV/EBITDA10.71
Gross margin—
Net margin0.97%
Rev growth3.63%
EPS growth107.07%
Price target29.75
Target upside22.25%
Analyst ratingBuy
Institutional123.25%
Ent. value1.18B
Revenue177.38M
Net income2.92M
Gross profit—
Free cash flow136.66M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees829
ListedThu, Feb 3, 2011
Free float37.93M
Float %93.7%
Short interest6.6M
Days to cover14.1d
Short volume73.3%
Squeeze score95 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.27 · 1 est
Last EPS vs est$0.34 vs $0.33
Last surprise+3.0% beat
Setup gradeC
Conviction54 / 100
Pattern quality—
Tech rank54.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance26.15
Support21.97
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PCRX
No recent disclosed trades by Congress in PCRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PCRX · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BIGAL MARCELO Director · Common Stock · 2026-06-10 | Grant | 6.41K | — | 2026-06-10 | 2026-06-12 |
BIGAL MARCELO Director · Stock Option (Right to Buy) · 2026-06-10 | Grant | 10.89K | — | 2026-06-10 | 2026-06-12 |
WILLIAMS KRISTEN Chief Administrative Officer · Common Stock · 2026-06-04 | Sell | 10.26K | $228K | 2026-06-04 | 2026-06-05 |
SLONIN JONATHAN Chief Medical Officer · Common Stock · 2026-06-03 | Tax | 4.73K | $106K | 2026-06-03 | 2026-06-05 |
WILLIAMS KRISTEN Chief Administrative Officer · Common Stock · 2026-06-03 | Tax | 8.53K | $190K | 2026-06-03 | 2026-06-05 |
RIKER LAUREN Senior Vice President, Finance · Common Stock · 2026-06-03 | Tax | 3.19K | $71K | 2026-06-03 | 2026-06-05 |
Cross Shawn Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-23 | Exercise | 12.94K | $0 | 2026-04-23 | 2026-04-24 |
Cross Shawn Chief Financial Officer · Common Stock · 2026-04-23 | Sell | 12.94K | $326K | 2026-04-23 | 2026-04-24 |
Cross Shawn Chief Financial Officer · Common Stock · 2026-04-23 | Exercise | 12.94K | $213K | 2026-04-23 | 2026-04-24 |
Cross Shawn Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-22 | Exercise | 1.5K | $0 | 2026-04-22 | 2026-04-22 |
SEC filings
EDGAR filings in PCRX · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.